Trials on drug that eliminates interleukin-11 in mice show promising signs such as improved appearance, lower cancer rates, and increased lifespan reported in Nature journal.
Researchers aim to ascertain if the positive effects observed in mice can be replicated in human trials, with ongoing tests for lung fibrosis patients showing potential.
Collection
[
|
...
]